Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report.

Daneshpazhooh, Maryam

Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report. [electronic resource] - The Journal of dermatological treatment Aug 2020 - 446-447 p. digital

Publication Type: Case Reports; Journal Article

1471-1753

10.1080/09546634.2020.1764472 doi


Adult
Anti-Bacterial Agents--therapeutic use
Antiviral Agents--therapeutic use
Betacoronavirus
COVID-19
Coronavirus Infections--complications
Deprescriptions
Diabetes Mellitus, Type 2--complications
Drug Combinations
Drug Therapy, Combination
Humans
Hypertension--complications
Immunoglobulins, Intravenous--therapeutic use
Immunologic Factors--therapeutic use
Iran
Lopinavir--therapeutic use
Male
Mycophenolic Acid--therapeutic use
Oseltamivir--therapeutic use
Pandemics
Pemphigoid, Benign Mucous Membrane--complications
Pneumonia, Viral--complications
Prednisolone--therapeutic use
Ritonavir--therapeutic use
Rituximab--therapeutic use
SARS-CoV-2
Tomography, Spiral Computed
COVID-19 Drug Treatment